Healthcare professionals’ perspective can guide post-marketing surveillance of artemisinin-based combination therapy in Uganda
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1475-2875
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Healthcare professionals’ perspective can guide post-marketing surveillance of artemisinin-based combination therapy in Uganda ; volume:19 ; number:1 ; day:10 ; month:2 ; year:2020 ; pages:1-12 ; date:12.2020
Malaria journal ; 19, Heft 1 (10.2.2020), 1-12, 12.2020
- Creator
-
Ndagije, Helen Byomire
Kiguba, Ronald
Manirakiza, Leonard
Kirabira, Elijah
Sserwanga, Allan
Nabirye, Leah
Mukonzo, Jackson
Olsson, Sten
Spinewine, Anne
D’Hoore, William
Speybroeck, Niko
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12936-020-3148-5
- URN
-
urn:nbn:de:101:1-2020051015102835197771
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:55 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Ndagije, Helen Byomire
- Kiguba, Ronald
- Manirakiza, Leonard
- Kirabira, Elijah
- Sserwanga, Allan
- Nabirye, Leah
- Mukonzo, Jackson
- Olsson, Sten
- Spinewine, Anne
- D’Hoore, William
- Speybroeck, Niko
- SpringerLink (Online service)
Other Objects (12)
Initial surveillance of suspected undesirable drug reactions to some Artemisinin-based combination therapies (ACTs) in Lagos, Nigeria
From chloroquine to artemisinin-based combination therapy: the Sudanese experience
Efficacy of non-artemisinin- and artemisinin-based combination therapies for uncomplicated falciparum malaria in Cameroon
Surveillance of genetic markers associated with Plasmodium falciparum resistance to artemisinin-based combination therapy in Pakistan, 2018–2019
Pharmacokinetics/pharmacodynamics of chloroquine and artemisinin-based combination therapy with primaquine
Artemisinin-based combination therapy for uncomplicated Plasmodium falciparum malaria in Colombia
Molecular surveillance for polymorphisms associated with artemisinin-based combination therapy resistance in Plasmodium falciparum isolates collected in Mozambique, 2018
Stabilizing supply of artemisinin and artemisinin-based combination therapy in an era of wide-spread scale-up
Treatment of malaria from monotherapy to artemisinin-based combination therapy by health professionals in rural health facilities in southern Cameroon
Predicting Global Fund grant disbursements for procurement of artemisinin-based combination therapies
Triple artemisinin-based combination therapy (TACT): advancing malaria control and eradication efforts
Novel artemisinin-based antiviral, antimalarial and anticancer hybrid compounds via click chemistry
Initial surveillance of suspected undesirable drug reactions to some Artemisinin-based combination therapies (ACTs) in Lagos, Nigeria
From chloroquine to artemisinin-based combination therapy: the Sudanese experience
Efficacy of non-artemisinin- and artemisinin-based combination therapies for uncomplicated falciparum malaria in Cameroon
Surveillance of genetic markers associated with Plasmodium falciparum resistance to artemisinin-based combination therapy in Pakistan, 2018–2019
Pharmacokinetics/pharmacodynamics of chloroquine and artemisinin-based combination therapy with primaquine
Artemisinin-based combination therapy for uncomplicated Plasmodium falciparum malaria in Colombia
Molecular surveillance for polymorphisms associated with artemisinin-based combination therapy resistance in Plasmodium falciparum isolates collected in Mozambique, 2018
Stabilizing supply of artemisinin and artemisinin-based combination therapy in an era of wide-spread scale-up
Treatment of malaria from monotherapy to artemisinin-based combination therapy by health professionals in rural health facilities in southern Cameroon
Predicting Global Fund grant disbursements for procurement of artemisinin-based combination therapies
Triple artemisinin-based combination therapy (TACT): advancing malaria control and eradication efforts
Novel artemisinin-based antiviral, antimalarial and anticancer hybrid compounds via click chemistry
Initial surveillance of suspected undesirable drug reactions to some Artemisinin-based combination therapies (ACTs) in Lagos, Nigeria
From chloroquine to artemisinin-based combination therapy: the Sudanese experience
Efficacy of non-artemisinin- and artemisinin-based combination therapies for uncomplicated falciparum malaria in Cameroon
Surveillance of genetic markers associated with Plasmodium falciparum resistance to artemisinin-based combination therapy in Pakistan, 2018–2019
Pharmacokinetics/pharmacodynamics of chloroquine and artemisinin-based combination therapy with primaquine
Artemisinin-based combination therapy for uncomplicated Plasmodium falciparum malaria in Colombia
Molecular surveillance for polymorphisms associated with artemisinin-based combination therapy resistance in Plasmodium falciparum isolates collected in Mozambique, 2018
Stabilizing supply of artemisinin and artemisinin-based combination therapy in an era of wide-spread scale-up
Treatment of malaria from monotherapy to artemisinin-based combination therapy by health professionals in rural health facilities in southern Cameroon
Predicting Global Fund grant disbursements for procurement of artemisinin-based combination therapies
Triple artemisinin-based combination therapy (TACT): advancing malaria control and eradication efforts